Cargando…
Supporting Huntington’s Disease Families Through the Ups and Downs of Clinical Trials
Recent years have been turbulent ones for the Huntington’s disease (HD) community. Three clinical trials for HD, including the first Phase 3 trial of a potentially disease modifying genetic therapy for HD, were all brought to a halt in March of 2021. 2022 brought more study roadblocks and an additio...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
IOS Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200140/ https://www.ncbi.nlm.nih.gov/pubmed/37038822 http://dx.doi.org/10.3233/JHD-230565 |